Home > Keywords > DSPE-
| Catalog | name | Description | price |
|---|---|---|---|
| R-C-4710 | DSPE-polyethylene glycol550-VSNKYFSNIHWGC | uPA peptide (VSNKYFSNIHWGC)-conjugated,antisense-miR-21 and antisense-miR-10b coloaded PLGA-b-PEG-NPs (called uPA-Anti-miR-21-Anti-miR-10b-NPs) that simultaneously antagonized miR-21-induced inhibition of apoptosis and miR-10b-induced metastasis to achieve TNBC therapy.Our products are only used for scientific research, not for human body. | price> |
| R-C-4723 | DSPE-PEG-RINNIPWSEAMMC | 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol is a long circulating liposome membrane, formation of micelles in water dispersion, the critical micelle concentration (CMC) ratio of surfactant is 102 times lower, so the drug stability is better, even by hemodilution, can maintain the integrity of the micelle particle, has certain targeting, easy accumulation in solid tumors. Peptide is a compound formed by α-amino acids linked together by peptide bond,which is the intermediate product of protein hydrolysis. | price> |
| R-C-4724 | DSPE-HYD-PEG-iRGD | DSPE-Hyd-PEG-iRGD is a PH-responsive liposome, which uses hydrazone bond to design PH-responsive nano drug micelles, and its core is composed of DOX connected by hydrazone bond. Under acidic conditions, the hydrazone bond breaks and the drug is released. When the drug carrier reaches the endosomes or lysosomes of tumor cells, acid hydrolysis will occur to release the drug, achieving the effect of targeted drug delivery. | price> |
| R-C-4725 | DSPE-HYD-polyethylene glycol350-iRGD | DSPE-Hyd-PEG-iRGD is a PH-responsive liposome, which uses hydrazone bond to design PH-responsive nano drug micelles, and its core is composed of DOX connected by hydrazone bond. Under acidic conditions, the hydrazone bond breaks and the drug is released. When the drug carrier reaches the endosomes or lysosomes of tumor cells, acid hydrolysis will occur to release the drug, achieving the effect of targeted drug delivery. | price> |
| R-C-4726 | DSPE-Hydrazide-PEG550-iRGD | DSPE-Hyd-PEG-iRGD is a PH-responsive liposome, which uses hydrazone bond to design PH-responsive nano drug micelles, and its core is composed of DOX connected by hydrazone bond. Under acidic conditions, the hydrazone bond breaks and the drug is released. When the drug carrier reaches the endosomes or lysosomes of tumor cells, acid hydrolysis will occur to release the drug, achieving the effect of targeted drug delivery. | price> |
| R-C-4727 | iRGD-PEG750-HYD-DSPE | DSPE-Hyd-PEG-iRGD is a PH-responsive liposome, which uses hydrazone bond to design PH-responsive nano drug micelles, and its core is composed of DOX connected by hydrazone bond. Under acidic conditions, the hydrazone bond breaks and the drug is released. When the drug carrier reaches the endosomes or lysosomes of tumor cells, acid hydrolysis will occur to release the drug, achieving the effect of targeted drug delivery. | price> |
| R-C-4731 | DSPE-PEG350-RINNIPWSEAMMC | 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol is a long circulating liposome membrane, formation of micelles in water dispersion, the critical micelle concentration (CMC) ratio of surfactant is 102 times lower, so the drug stability is better, even by hemodilution, can maintain the integrity of the micelle particle, has certain targeting, easy accumulation in solid tumors. Peptide is a compound formed by α-amino acids linked together by peptide bond,which is the intermediate product of protein hydrolysis. | price> |
| R-C-4733 | DSPE-polyethylene glycol550-RINNIPWSEAMMC | 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol is a long circulating liposome membrane, formation of micelles in water dispersion, the critical micelle concentration (CMC) ratio of surfactant is 102 times lower, so the drug stability is better, even by hemodilution, can maintain the integrity of the micelle particle, has certain targeting, easy accumulation in solid tumors. Peptide is a compound formed by α-amino acids linked together by peptide bond,which is the intermediate product of protein hydrolysis. | price> |
| R-C-4735 | DSPE-N3 CAS:2839508-98-2 | 1,2-Distearoyl-sn-Glycero-3-Phosphoethanolamine-N-azide(DSPE-azide,DSPE-N3)is a phophalipid capped with azide group.The azide capped head can be used to react with alkynes cyclocytidine in an aqueous solution with or without copper catalyst;18:0PE N3; Phospholipid-azide;The primary amino group of DSPE directly modifies the N3 active group. | price> |
| R-C-4740 | DSPE-PEG-TK-MAL | DSPE-PEG2k-TK-MAL,DSPE phospholipids have the function of emulsifying and solubilizing drugs as pharmaceutical excipients. Modification of phospholipid molecules can make these preparations have the ability to release and target under specific conditions. Common modification methods include:; Introduce polymer to improve the blood circulation time and disintegration time of the preparation; Introducing rabbit epidemic factor to enhance targeting; Introduce markers for diagnosis and tracking. | price> |
| R-C-4741 | DSPE-PEG350-TK-MAL | DSPE phospholipids have the function of emulsifying and solubilizing drugs as pharmaceutical excipients. Modification of phospholipid molecules can make these preparations have the ability to release and target under specific conditions. Common modification methods include:; Introduce polymer to improve the blood circulation time and disintegration time of the preparation; Introducing rabbit epidemic factor to enhance targeting; Introduce markers for diagnosis and tracking. | price> |
| R-C-4742 | DSPE-polyethylene glycol550-TK-MAL | DSPE phospholipids have the function of emulsifying and solubilizing drugs as pharmaceutical excipients. Modification of phospholipid molecules can make these preparations have the ability to release and target under specific conditions. Common modification methods include:; Introduce polymer to improve the blood circulation time and disintegration time of the preparation; Introducing rabbit epidemic factor to enhance targeting; Introduce markers for diagnosis and tracking. | price> |
| R-C-4744 | DSPE-PEG-GSH | DSPE phospholipids have the functions of emulsification and drug solubilization as pharmaceutical excipients, and are important materials for slow-release and controlled-release drug preparations such as liposomes, fat emulsions and nanoparticles in recent years. The modification of phospholipid molecules can make these preparations have the ability to release and target under specific conditions. GSH is a blood-brain barrier shuttle peptide that can transport NPs to the blood-brain barrier through GSH transport protein. | price> |
| R-C-4745 | DSPE-PEG350-Glutathione | DSPE phospholipids have the functions of emulsification and drug solubilization as pharmaceutical excipients, and are important materials for slow-release and controlled-release drug preparations such as liposomes, fat emulsions and nanoparticles in recent years. The modification of phospholipid molecules can make these preparations have the ability to release and target under specific conditions. GSH is a blood-brain barrier shuttle peptide that can transport NPs to the blood-brain barrier through GSH transport protein. | price> |
| R-C-4746 | DSPE-polyethylene glycol550-GSH | DSPE phospholipids have the functions of emulsification and drug solubilization as pharmaceutical excipients, and are important materials for slow-release and controlled-release drug preparations such as liposomes, fat emulsions and nanoparticles in recent years. The modification of phospholipid molecules can make these preparations have the ability to release and target under specific conditions. GSH is a blood-brain barrier shuttle peptide that can transport NPs to the blood-brain barrier through GSH transport protein. | price> |
| R-C-4747 | DSPE-PEG750-Glutathione | DSPE phospholipids have the functions of emulsification and drug solubilization as pharmaceutical excipients, and are important materials for slow-release and controlled-release drug preparations such as liposomes, fat emulsions and nanoparticles in recent years. The modification of phospholipid molecules can make these preparations have the ability to release and target under specific conditions. GSH is a blood-brain barrier shuttle peptide that can transport NPs to the blood-brain barrier through GSH transport protein. | price> |
| R-C-4753 | DSPE-PEG-cRGD-FITC | Pegylated phospholipids are excellent liposome formation materials that can be used for drug delivery, gene transfection and vaccine delivery as well. Pegylation of phospholipids significantly improves the blood circulation time and stability for encapsulated drugs. Fluorescein labeled DSPE PEG products emitted green fluorescence and can be easily detected with fluorescent microscopy or spectroscopy.cRGD is an active target material,It can be used as an antitumor drug carrier and active targeted delivery. | price> |
| R-C-4754 | DSPE-PEG-peptide(PPGAYHGA) | The polyethylene glycol copolymer with biodegradable and biocompatible polyester chain segments can also be used to prepare core-shell micelles, nanoparticles and microspheres.The active group at the end of the product can link some modified peptides,proteins,carbohydrates,folic acid or antibodies to make them have active targeting effect. | price> |
| R-C-4755 | DSPE-polyethylene-glycol350-peptide(PPGAYHGA) | The polyethylene glycol copolymer with biodegradable and biocompatible polyester chain segments can also be used to prepare core-shell micelles,nanoparticles and microspheres.The active group at the end of the product can link some modified peptides,proteins,carbohydrates,folic acid or antibodies to make them have active targeting effect. | price> |
| R-C-4757 | DSPE-PEG750-PPGAYHGA | The polyethylene glycol copolymer with biodegradable and biocompatible polyester chain segments can also be used to prepare core-shell micelles, nanoparticles and microspheres.The active group at the end of the product can link some modified peptides,proteins,carbohydrates,folic acid or antibodies to make them have active targeting effect. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


